MKI67 and hepatocellular carcinoma: A total of 94 HCC patients were included in this study (51 patients in the Ki-67 high-expression group and 43 patients in the Ki-67 low-expression group; 49 patients in the GPC-3-positive group and 45 patients in the GPC-3-negative group) as shown in Table 1.